All type of patients: 3 trials - PROTECT-TIMI 30 - HERO - BAT (Bittl)
Patients managed with an early invasive strategy: 2 trials - ACUITY (biva alone vs hep+aGP2b3a) - ACUITY (biva+aGP2b3a vs hep+aGP2b3a)
PCI sub group: 2 trials - ACUITY (sub groups PCI, bivalirudin +aGP2b3a) importé - ACUITY (sub groups PCI, bivalirudin alone) importé
All type of patients: 10 trials - NAPLES (Tavano) - HORIZONS-AMI (Stone) - ISAR-REACT 3 - ACUITY (Stone) (bivalirudin alone) - REPLACE-1 - REPLACE-2 - Kleiman - BAT (Bittl) - ARMYDA BIVALVE - BRAVE-4